Monday, September 21, 2015 4:34:23 PM
Radius Health, Inc. is up 25% in the last 3-month period. Year-to-Date the stock performance stands at 92.75%. The company shares have rallied 390.2% in the past 52 Weeks. On July 15, 2015 The shares registered one year high of $84.64 and one year low was seen on September 22, 2014 at $14.65. The 50-day moving average is $67.23 and the 200 day moving average is recorded at $55.79. S&P 500 has rallied 1.82% during the last 52-weeks.
Radius Health, Inc. (NASDAQ:RDUS) : On Friday heightened volatility was witnessed in Radius Health, Inc. (NASDAQ:RDUS) which led to swings in the share price. The shares opened for trading at $72.4 and hit $75 on the upside , eventually ending the session at $75, with a gain of 3.18% or 2.31 points. The heightened volatility saw the trading volume jump to 1,292,142 shares. The 52-week high of the share price is $84.64 and the company has a market cap of $3,209 million. The 52-week low of the share price is at $14.1 .
Radius Health, Inc. (NASDAQ:RDUS): 6 Analyst have given the stock of Radius Health, Inc. (NASDAQ:RDUS) a near short term price target of $73.83. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $18.86. The higher price target estimate is at $90 while the lower price estimates are fixed at $50.
On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The Securities and Exchange Commission has divulged in a Form 4 filing that the officer (SVP Global Oncology/Commercial) of Radius Health, Inc., Purandare Dinesh had purchased shares worth of $12,440 in a transaction dated on August 31, 2015. A total of 200 shares were purchased at a price of $62.2 per share. The information is based on open market trades at the market prices.Option exercises are not covered. Currently the company Insiders own 37.4% of Radius Health, Inc. Company shares. In the past six months, there is a change of 2.73% in the total insider ownership. Institutional Investors own 73.5% of Company shares. During last 3 month period, 7.07% of total institutional ownership has changed in the company shares.
Radius Health, Inc. is a science-driven biopharmaceutical company focused on developing therapeutics for patients with osteoporosis, as well as other serious endocrine-mediated diseases. The Companys lead product candidate is abaloparatide (BA058), a bone anabolic for the treatment of osteoporosis delivered via subcutaneous injection, which it refers to as Abaloparatide-SC. The Company is leveraging its investment in Abaloparatide-SC to develop Abaloparatide-TD. The Companys clinical product portfolio also includes a oral agent, RAD1901, a selective estrogen receptor down-regulator/degrader, or SERD. The Companys Abaloparatide is a synthetic peptide analog of parathyroid hormone-related protein (PTHrP), that the Company is developing as a bone anabolic treatment for osteoporosis. The Company is also developing RAD1901 at lower doses as a selective estrogen receptor modulator (SERM), for the treatment of vasomotor symptoms.
http://newswatchinternational.com/news/company-shares-of-radius-health-inc-nasdaqrdus-rally-10-17.html
Recent RDUS News
- Radius Recycling Announces Fourth Quarter and Fiscal 2024 Earnings Date and Webcast Details • GlobeNewswire Inc. • 09/26/2024 12:30:00 PM
- Radius Recycling Reports Third Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 07/02/2024 12:00:00 PM
- Radius Recycling Announces Third Quarter Fiscal 2024 Earnings Date and Webcast Details • GlobeNewswire Inc. • 06/18/2024 09:10:00 PM
- Radius Recycling Reports Second Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 04/04/2024 12:00:00 PM
- US Index Futures Rise, Oil Dips Slightly • IH Market News • 04/04/2024 11:31:45 AM
- Second Quarter Fiscal 2024 Preliminary Results and Announcement of Earnings Date • GlobeNewswire Inc. • 03/14/2024 08:35:00 PM
- Radius Recycling Named One of the 2024 World’s Most Ethical Companies • Business Wire • 03/04/2024 01:30:00 PM
- Radius Recycling Reports First Quarter Fiscal 2024 Financial Results • Business Wire • 01/04/2024 01:00:00 PM
- Radius Recycling Announces First Quarter Fiscal 2024 Earnings Date and Webcast Details • Business Wire • 12/18/2023 02:00:00 PM
- Radius Recycling Publishes Fiscal Year 2023 Sustainability Report • Business Wire • 12/13/2023 02:15:00 PM
- Radius Recycling Executive Included on TIME100 Climate List of the 100 Most Influential Leaders Driving Business Climate Action • Business Wire • 11/16/2023 01:30:00 PM
- Radius Recycling Reports Fourth Quarter and Fiscal 2023 Financial Results • Business Wire • 10/25/2023 12:00:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM